YOU ARE HERE:
HIV & AIDS Treatment in Practice #8, 26 June 2003
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings. It is supported by and produced in collaboration with St Stephen's AIDS Trust and the International HIV/AIDS Alliance.

Its publication is also supported by Positive Action of GlaxoSmithKline, Boehringer Ingelheim and the Access 4 Trust.
   Last updated: 18.06.04
IN THIS ISSUE
About HIV & AIDS Treatment in Practice
News links from www.aidsmap.com (see below)
Scaling Up Antiretroviral Therapy (main feature)

NEWS LINKS FROM WWW.AIDSMAP.COM
A selection of news stories which have appeared since 12 June 2003

UNAIDS says US$4.7 billion to be spent on HIV in poorer countries in 2003, US$10.5 needed by 2005
  • Less than half of the US$10.5 billion needed for to address the AIDS epidemic in low and middle-income countries by 2005 will be spent on the epidemic in 2003, according to a UNAIDS published on June 26th.


EU fails to commit 1 billion euros to Global Fund
  • Despite, pressure from the United Kingdom, France and President Bush, EU leaders failed to commit to donating €1 billion euros to the Global Fund to Fight AIDS, TB and Malaria at last weekend's EU Summit in Greece, agreeing instead `to make a substantial contribution`. The formula was agreed because Germany, the Netherlands and several other smaller states said that they could not afford to give more support because of ongoing budgetary problems.


Adherence in Cape Town poor just as good as US and Europe
  • In South Africa, the presumption that indigent patients might not stick to pill-taking schedules has served as an excuse to delay the extension of antiretroviral treatment to the HIV-infected population. However, according to a study published in the June 12th edition of AIDS by Dr. Catherine Orrell et al., "adherence is not a barrier to successful antiretroviral therapy in South Africa."


TB checks in HIV care valuable for new mums in South Africa
  • Health care workers at the Chris Hani Baragwanath Hospital in Soweto, South Africa, have shown that offering routine TB checks for new mothers with HIV (and their male partners) can identify many previously unsuspected cases in need of treatment.


Private prescribing biggest risk for developing world drug resistance
  • Unless HIV treatment is properly controlled in developing countries, antiretroviral therapy could become useless due to poor practice in the private sector, according to an editorial in the June 21 edition of the British Medical Journal by Ruairi Brugha, a senior lecturer in public health at the London School of Hygiene and Tropical Medicine.


Three per cent of men who have sex with men HIV-positive in Beijing
  • Researchers from China and the USA suggest in this week's issue of The Lancet that men who have unprotected sex with men might worsen China's emerging HIV-1 epidemic because they form a sexual bridge between men and women.


Sex, not injections, drives HIV epidemic in Zimbabwe
  • In the last year, several researchers have challenged the view that the HIV epidemic in Southern Africa is the result of sexual transmission, arguing that poor medical practice – and especially the re-use of syringes for injections - plays a bigger role than previously recognised. This claim is now strongly challenged in the journal AIDS by researchers working in Zimbabwe, based on a study of hepatitis C virus (HCV) prevalence among people living with HIV.


Exercise linked to lower triglyceride levels on HAART
  • People who exercise more show fewer signs of a major metabolic disturbance associated with HIV therapy – elevated triglyceride levels - according to a study of 120 HIV-positive patients at Boston’s Beth Israel Medical Centre, published this week in the June 15th edition of Clinical Infectious Diseases.


Diet changes successfully reduce cholesterol in HAART-treated patients
  • Diet modification can successfully reduce cholesterol levels in HAART-treated HIV-positive patients, according to a small study published in the June 13th edition of the journal AIDS.


Do cholesterol rises in HAART-treated men reflect normalisation, or treatment side-effect?
  • A US study published in the June 11th edition of the Journal of the American Medical Association suggests that the increases in cholesterol levels seen in HAART-treated patients represent a normalisation of total and LDL cholesterol levels rather than a harmful consequence of therapy.




aidsmap resources